Voriconazole and Posaconazole Improve Asthma Severity in Allergic Bronchopulmonary Aspergillosis and Severe Asthma with Fungal Sensitization

References

• Denning DW, O’Driscoll BR, Hogaboam CM, Bowyer P, Niven RM. The link between fungi and severe asthma: a summary of the evidence. Eur Respir J 2006; 27(3):615–626.
   PubMed Web of Science ®Google Scholar
• Porter P, Susarla SC, Polikepahad S, Qian Y, Hampton J, Kiss A, Vaidya S, Sur S, Ongeri V, Yang T, Delclos GL, Abramson S, Kheradmand F, Corry DB. Link between allergic asthma and airway mucosal infection suggested by proteinase-secreting household fungi. Mucosal Immunol 2009; 2(6):504–517.
   PubMed Web of Science ®Google Scholar
• Madani Y, Barlow A, Taher F. Severe asthma with fungal sensitization: a case report and review of literature. J Asthma 2010; 47(1):2–6.
   PubMed Web of Science ®Google Scholar
• Agarwal R, Nath A, Aggarwal AN, Gupta D, Chakrabarti A. Aspergillus hypersensitivity and allergic bronchopulmonary aspergillosis in patients with acute severe asthma in a respiratory intensive care unit in North India. Mycoses 2009; 53(2):138–143.
   PubMed Web of Science ®Google Scholar
• O’Driscoll BR, Hopkinson LC, Denning DW. Mold sensitization is common amongst patients with severe asthma requiring multiple hospital admissions. BMC Pulm Med 2005; 5:4.
   PubMedGoogle Scholar
• Donnelly SC, McLaughlin H, Bredin CP. Period prevalence of allergic bronchopulmonary mycosis in a regional hospital outpatient population in Ireland 1985–88. Ir J Med Sci 1991; 160(9):288–290.
   PubMed Web of Science ®Google Scholar
• Eaton T, Garrett J, Milne D, Frankel A, Wells AU. Allergic bronchopulmonary aspergillosis in the asthma clinic. A prospective evaluation of CT in the diagnostic algorithm. Chest 2000; 118(1):66–72.
   Google Scholar
• Patterson R, Greenberger PA, Halwig JM, Liotta JL, Roberts M. Allergic bronchopulmonary aspergillosis. Natural history and classification of early disease by serologic and roentgenographic studies. Arch Intern Med 1986; 146(5):916–918.
   PubMedGoogle Scholar
• Chetty A. Pathology of allergic bronchopulmonary aspergillosis. Front Biosci 2003; 8:e110–e114.
   Web of Science ®Google Scholar
• Safirstein BH, D‘Souza MF, Simon G, Tai EH, Pepys J. Five-year follow-up of allergic bronchopulmonary aspergillosis. Am Rev Respir Dis 1973; 108(3):450–459.
   PubMed Web of Science ®Google Scholar
• Smith NL, Denning DW. Underlying conditions in chronic pulmonary aspergillosis, including simple aspergilloma. Eur Respir J. 2011 Apr;37(4):865–872. Epub 2010 Jul 1.
   Google Scholar
• O’Connor TM, O’Donnell A, Hurley M, Bredin CP. Allergic bronchopulmonary aspergillosis: a rare cause of pleural effusion. Respirology 2001; 6(4):361–363.
   PubMedGoogle Scholar
• Fairs A, Agbetile J, Hargadon B, Bourne M, Monteiro WR, Brightling CE, Bradding P, Green RH, Mutalithas K, Desai D, Pavord ID, Wardlaw AJ, Pashley CH. IgE sensitization to Aspergillus fumigatus is associated with reduced lung function in asthma. Am J Respir Crit Care Med 2010; 182(11):1362–1368.
   PubMed Web of Science ®Google Scholar
• Greenberger PA. Diagnosis and management of allergic bronchopulmonary aspergillosis. Allergy Proc 1994; 15(6):335–339.
   PubMedGoogle Scholar
• Imbeau SA, Nichols D, Flaherty D, Dickie H, Reed C. Relationships between prednisone therapy, disease activity, and the total serum IgE level in allergic bronchopulmonary aspergillosis. J Allergy Clin Immunol 1978; 62(2):91–95.
   PubMed Web of Science ®Google Scholar
• Clayton DE, Busse WW. Development of allergic bronchopulmonary aspergillosis during treatment of severe asthma with systemic corticosteroids. J Allergy Clin Immunol 1981; 67(3):243–246.
   PubMed Web of Science ®Google Scholar
• Laufer P. Assessment of corticosteroid therapy for allergic bronchopulmonary aspergillosis in a patient with cystic fibrosis. J Asthma 1985; 22(5):253–255.
   PubMed Web of Science ®Google Scholar
• Zhang DH, Li HD, Zheng L. [Diagnosis and treatment of allergic bronchopulmonary aspergillosis]. Zhonghua Nei Ke Za Zhi 1987; 26(1):6–8.
   PubMedGoogle Scholar
• Heinig JH, Weeke ER, Groth S, Schwartz B. High-dose local steroid treatment in bronchopulmonary aspergillosis. A pilot study. Allergy 1988; 43(1):24–31.
   PubMed Web of Science ®Google Scholar
• Denning DW, Van Wye JE, Lewiston NJ, Stevens DA. Adjunctive therapy of allergic bronchopulmonary aspergillosis with itraconazole. Chest 1991; 100(3):813–819.
   PubMed Web of Science ®Google Scholar
• Fujimori Y, Tada S, Kataoka M, Kawaraya M, Ikubo S, Horiba M, Okahara M, Takehara H, Harada M, Tanabe K. Allergic bronchopulmonary aspergillosis effectively treated with itraconazole. Nihon Kokyuki Gakkai Zasshi 1998; 36(9):781–786.
   PubMedGoogle Scholar
• Nikaido Y, Nagata N, Yamamoto T, Yoshii C, Ohmori H, Kido M. A case of allergic bronchopulmonary aspergillosis successfully treated with itraconazole. Respir Med 1998; 92(1):118–119.
   PubMed Web of Science ®Google Scholar
• Leon EE, Craig TJ. Antifungals in the treatment of allergic bronchopulmonary aspergillosis. Ann Allergy Asthma Immunol 1999; 82(6):511–516, quiz 516–519.
   PubMed Web of Science ®Google Scholar
• Fink JN. Therapy of allergic bronchopulmonary aspergillosis. Indian J Chest Dis Allied Sci 2000; 42(4):221–224.
   PubMedGoogle Scholar
• Wark P. Pathogenesis of allergic bronchopulmonary aspergillosis and an evidence-based review of azoles in treatment. Respir Med 2004; 98(10):915–923.
   PubMed Web of Science ®Google Scholar
• Wark PA, Gibson PG, Wilson AJ. Azoles for allergic bronchopulmonary aspergillosis associated with asthma. Cochrane Database Syst Rev 2003; 3:CD001108.
   Google Scholar
• Pasqualotto AC, Powell G, Niven R, Denning DW. The effects of antifungal therapy on severe asthma with fungal sensitization and allergic bronchopulmonary aspergillosis. Respirology 2009; 14(8):1121–1127.
   PubMed Web of Science ®Google Scholar
• Denning DW, O’Driscoll BR, Powell G, Chew F, Atherton GT, Vyas A, Miles J, Morris J, Niven RM. Randomized controlled trial of oral antifungal treatment for severe asthma with fungal sensitization: the Fungal Asthma Sensitization Trial (FAST) study. Am J Respir Crit Care Med 2009; 179(1):11–18.
   PubMed Web of Science ®Google Scholar
• Tucker RM, Haq Y, Denning DW, Stevens DA. Adverse events associated with itraconazole in 189 patients on chronic therapy. J Antimicrob Chemother 1990; 26(4):561–566.
   PubMed Web of Science ®Google Scholar
• Lestner JM, Roberts SA, Moore CB, Howard SJ, Denning DW, Hope WW. Toxicodynamics of itraconazole: implications for therapeutic drug monitoring. Clin Infect Dis 2009; 49(6):928–930.
   PubMed Web of Science ®Google Scholar
• Baxter CG, Marshall A, Roberts M, Felton TW, Denning DW. Peripheral neuropathy in patients on long-term triazole antifungal therapy. J Antimicrob Chemother 2011; 66(9):2136–2139.
   PubMed Web of Science ®Google Scholar
• Skov M, Main KM, Sillesen IB, Müller J, Koch C Lanng S. Iatrogenic adrenal insufficiency as a side-effect of combined treatment of itraconazole and budesonide. Eur Respir J 2002; 20(1):127–133.
   PubMed Web of Science ®Google Scholar
• Slordal L, Spigset O. Heart failure induced by non-cardiac drugs. Drug Saf 2006; 29(7):567–586.
   PubMed Web of Science ®Google Scholar
• Hilliard T, Edwards S, Buchdahl R, Francis J, Rosenthal M, Balfour-Lynn I, Bush A, Davies J. Voriconazole therapy in children with cystic fibrosis. J Cyst Fibros 2005; 4(4):215–220.
   PubMedGoogle Scholar
• Glackin L, Leen G, Elnazir B, Greally P. Voriconazole in the treatment of allergic bronchopulmonary aspergillosis in cystic fibrosis. Ir Med J 2009; 102(1):29.
   PubMedGoogle Scholar
• Ricketti AJ, Greenberger PA, Mintzer RA, Patterson R. Allergic bronchopulmonary aspergillosis. Arch Intern Med 1983; 143(8):1553–1557.
   PubMedGoogle Scholar
• Patterson R, Greenberger PA, Harris KE. Allergic bronchopulmonary aspergillosis. Chest 2000; 118(1):7–8.
   PubMed Web of Science ®Google Scholar
• Clancy K. British guidelines on the management of asthma. Thorax 2004; 59(1):81–82.
   PubMed Web of Science ®Google Scholar
• Andes D, Pascual A, Marchetti O. Antifungal therapeutic drug monitoring: established and emerging indications. Antimicrob Agents Chemother 2009; 53(1):24–34.
   PubMed Web of Science ®Google Scholar
• Felton TW, Baxter C, Moore CB, Roberts SA, Hope WW, Denning DW. Efficacy and safety of posaconazole for chronic pulmonary aspergillosis. Clin Infect Dis 2010; 51(12):1383–1391.
   PubMed Web of Science ®Google Scholar
• Cockcroft DW, Swystun VA. Asthma control versus asthma severity. J Allergy Clin Immunol 1996; 98(6 Pt 1):1016–1018.
   PubMed Web of Science ®Google Scholar
• Zervas E, Oikonomidou E, Kainis E, Kokkala M, Petroheilou K, Gaga M. Control of asthma. Ther Adv Respir Dis 2008; 2(3):141–148.
   PubMedGoogle Scholar
• Bateman ED, Hurd SS, Barnes PJ, Bousquet J, Drazen JM, FitzGerald M, Gibson P, Ohta K, O’Byrne P, Pedersen SE, Pizzichini E, Sullivan SD, Wenzel SE, Zar HJ. Global strategy for asthma management and prevention: GINA executive summary. Eur Respir J 2008; 31(1):143–178.
   PubMed Web of Science ®Google Scholar
• Agarwal R, Gupta D. Severe asthma and fungi: current evidence. Med Mycol. 2011 Apr;49 Suppl 1:S150-7. Epub 2010 Jul 22.
   Google Scholar
• Bandres Gimeno R, Munoz Martinez MJ. Prolonged therapeutic response to voriconazole in a case of allergic bronchopulmonary aspergillosis. Arch Bronconeumol 2007; 43(1):49–51.
   PubMed Web of Science ®Google Scholar
• Soto-Quiros ME. Practical handling of the asthma based on the control of the disease: update of GINA guidelines. An Pediatr (Barc) 2008; 68(4):317–319.
   PubMedGoogle Scholar
• Koshak EA. Classification of asthma according to revised 2006 GINA: evolution from severity to control. Ann Thorac Med 2007; 2(2):45–46.
   PubMedGoogle Scholar
• Turner S, Paton J, Higgins B, Douglas G; British Guidelines on the Management of Asthma. British guidelines on the management of asthma: what’s new for 2011? Thorax 2011; 66(12):1104–1105.
   PubMed Web of Science ®Google Scholar
• Wenzel S. Severe asthma in adults. Am J Respir Crit Care Med 2005; 172(2):149–160.
   PubMed Web of Science ®Google Scholar
• Lai CK, Ko FW, Bhome A, DE Guia TS, Wong GW, Zainudin BM, Nang AN, Boonsawat W, Cho SH, Gunasekera KD, Hong JG, Hsu JY, Viet NN, Yunus F, Mukhopadhyay A. Relationship between asthma control status, the asthma control test and urgent health-care utilization in Asia. Respirology 2011; 16(4):688–697.
   PubMed Web of Science ®Google Scholar
• Nickel R, Illi S, Lau S, Sommerfeld C, Bergmann R, Kamin W, Forster J, Schuster A, Niggemann B, Wahn U; German Multicenter Allergy Study Group (MAS-90). Variability of total serum immunoglobulin E levels from birth to the age of 10 years. A prospective evaluation in a large birth cohort (German Multicenter Allergy Study). Clin Exp Allergy 2005; 35(5):619–623.
   Google Scholar
• British Thoracic Society, Scottish Intercollegiate Guidelines Network. British Guideline on the Management of Asthma, A national clinical guideline,www.sign.ac.uk, Thorax. 2008 May;63 Suppl 4:iv1–121.
   Google Scholar
• Levy ML, Thomas M, Small I, Pearce L, Pinnock H, Stephenson P. Summary of the 2008 BTS/SIGN British guideline on the management of asthma. Prim Care Respir J 2009; 18(Suppl. 1):S1–S16.
   PubMedGoogle Scholar
• Boulet LP, Becker A, Bérubé D, Ernst P, Beveridge R. 1998 revision of the Canadian asthma consensus guidelines. asthma consensus conference editorial committee. Can Respir J 1999; 6(3):231–232.
   PubMedGoogle Scholar
• Boulet LP, Becker A, Bérubé D, Beveridge R, Ernst P. Canadian asthma consensus report, 1999. Canadian asthma consensus group. CMAJ 1999; 161(11 Suppl.):S1–S61.
   PubMed Web of Science ®Google Scholar
• Pascual RM, Peters SP. Airway remodeling contributes to the progressive loss of lung function in asthma: an overview. J Allergy Clin Immunol 2005; 116(3):477–486, quiz 487.
   PubMed Web of Science ®Google Scholar
• Epaulard O, Leccia MT, Blanche S, Chosidow O, Mamzer-Bruneel MF, Ravaud P, Thiebaut A, Villier C, Lortholary O. Phototoxicity and photocarcinogenesis associated with voriconazole. Med Mal Infect 2011; 41(12):639–645.
   PubMed Web of Science ®Google Scholar
• Cowen EW, Nguyen JC, Miller DD, McShane D, Arron ST, Prose NS, Turner ML, Fox LP. Chronic phototoxicity and aggressive squamous cell carcinoma of the skin in children and adults during treatment with voriconazole. J Am Acad Dermatol 2010; 62(1):31–37.
   PubMed Web of Science ®Google Scholar
• Moton A, Krishna G, Wang Z. Tolerability and safety profile of posaconazole: evaluation of 18 controlled studies in healthy volunteers. J Clin Pharm Ther 2009; 34(3):301–311.
   PubMed Web of Science ®Google Scholar
• Juniper EF, Chauhan A, Neville E, Chatterjee A, Svensson K, Mörk AC, Ståhl E. Clinicians tend to overestimate improvements in asthma control: an unexpected observation. Prim Care Respir J 2004; 13(4):181–184.
   PubMedGoogle Scholar